by Asmaa Javed | Jan 23, 2025 | Past Awards
Drs. Egle Kvedaraite (Karolinska Institutet, Solna, Sweden) Dr. Egle Kvedaraite is a Postdoctoral Fellow with the Department of Pathology and Cancer Diagnostics at the Karolinska University Hospital – Unit of Molecular Neurobiology in Stockholm, Sweden. Dr. Kvedaraite...
by Asmaa Javed | Jan 23, 2025 | Past Awards
Gaurav Goyal (University of Alabama at Birmingham, Birmingham, AL US) The prognosis of ECD has improved tremendously due to the approval of targeted therapies. However, these treatments are administered for prolonged duration and can lead to side effects and...
by Asmaa Javed | Jan 23, 2025 | Past Awards
Francesco Peyronel, MD (Meyer Children’s University Hospital – IRCCS, Firenze, Italy) Survival of patients affected by Erdheim-Chester disease (ECD) has substantially improved over the last decades, thanks to the increased awareness of the disease, the consequent...
by Asmaa Javed | Jan 23, 2025 | Past Awards
Marina Ferrarini, MD Lorenzo Dagna, MD Marina Ferrarini, MD, and Lorenzo Dagna, MD were awarded $50,000 for their project, “Tailoring Treatment for Erdheim-Chester Disease.” The Ferrarini and Dagna study focuses on understanding how malignant cells in ECD patients...
by Asmaa Javed | Jan 23, 2025 | Past Awards
Matthew Collin (Newcastle University, Newcastle upon Tyne, UK) Eli Diamond, MD (Memorial Sloan Kettering Cancer Center, New York, NY US) The 2014 grant was awarded to principal investigators Eli Diamond, MD from Memorial Sloan-Kettering Cancer Center in New York, and...